"
Team:Buenos Aires/Results/BBsTesting
From 2012.igem.org
(→Week 3: Synthetic Ecology Characterization) |
Manugimenez (Talk | contribs) (→Week 1&2 : Yeast expression vectors & Transformations) |
||
| Line 21: | Line 21: | ||
The cloning we did was: | The cloning we did was: | ||
| - | + | ||
| - | pCM182 (TRPa) | + | {| class="wikitable" |
| - | pCM185 (TRPb) | + | | |
| - | pEG202 (HIS) X | + | ! scope="row" style="background: #7ac5e8"|<partinfo>BBa_K792009</partinfo> (PoliHa) |
| + | ! scope="row" style="background: #7ac5e8"|<partinfo>BBa_K792010</partinfo> (TRPZipper2) | ||
| + | ! scope="row" style="background: #7ac5e8"|<partinfo>BBa_K792011</partinfo> (PoliHb) | ||
| + | ! scope="row" style="background: #7ac5e8"|<partinfo>BBa_K792012</partinfo> (PoliWb) | ||
| + | |- | ||
| + | ! scope="row" style="background: #81BEF7"|pCM182 (TRPa) | ||
| + | | | ||
| + | ! scope="row" style="background: #01DF01"|X | ||
| + | | | ||
| + | ! scope="row" style="background: #01DF01"|X | ||
| + | |- | ||
| + | ! scope="row" style="background: #81BEF7"|pCM185 (TRPb) | ||
| + | | | ||
| + | ! scope="row" style="background: #01DF01"|X | ||
| + | | | ||
| + | ! scope="row" style="background: #01DF01"|X | ||
| + | |- | ||
| + | ! scope="row" style="background: #81BEF7"|pEG202 (HIS) | ||
| + | ! scope="row" style="background: #01DF01"|X | ||
| + | | | ||
| + | ! scope="row" style="background: #01DF01"|X | ||
| + | | | ||
| + | |} | ||
Revision as of 23:14, 26 October 2012
Contents |
After the Jamboree!
When we returned from the Latin America Jamboree we focused all our efforts on completing the neccesary transformations to test our devices and our projet as a whole.
We devided this task in three sections
Week 1&2 : Yeast expression vectors & Transformations
In order to construct the yeast expression plasmids we choosed 3 vectors, 2 with a tryptophan marker and 1 with an histidine marker:
- pCM182/5, which are centromeric plasmids with TRP1 marker, and with a doxycycline repressible promoter [Gari et al 1996].
- pEG202, with a 2 ori, HIS3 marker and a constitutive promoter (PADH1).
| 340px |
The cloning we did was:
| <partinfo>BBa_K792009</partinfo> (PoliHa) | <partinfo>BBa_K792010</partinfo> (TRPZipper2) | <partinfo>BBa_K792011</partinfo> (PoliHb) | <partinfo>BBa_K792012</partinfo> (PoliWb) | |
|---|---|---|---|---|
| pCM182 (TRPa) | X | X | ||
| pCM185 (TRPb) | X | X | ||
| pEG202 (HIS) | X | X |
Protocol
- Digestion of plasmids and TRP/HIS export device:
a. pCM182; pCM 185; BBa_K792010 y BBa_K792012 were digested with BamHI and Pst1 restriction enzymes. b. pEG202; BBa_K792009 y BBa_K792011 were digested with BamHI and Not1.
- Purification of digested vectors (pCM185; pCM182; pEG202)
- Ligation of vectors and devices according the anterior table (T4 ligase protocol, overnight)
- Transformation of E. Coli DH5a with the ligation products. Bacterias were plated on LB-agar with ampicilin, and incubated over night at 37 °C.
- Colonies were used for liquid cultures (LB + Ampicilin) and minipreps were made.
- Constructions (vector + insert) were checked by digestion with restriction enzymes, and 1%-agarose gel (1kb and 100bp as markers).
Once obtained the desired constructions, we transformed yeast strains:
- TCY3081: W303, bar1-, ura3::PAct1-YFP
- TCY3128: W303, bar1-, leu2:: Pprm1-CFP 405
TCY3081 (YFP) TCY3128 (CFP) Strain Name pCM182 (TRPa) + BBa_K792010 (TRPZipper2) X YFP_TRPa_TRPZipper2 pCM182 (TRPa) + BBa_K792012 (PoliWb) X YFP_TRPa_PoliWb pCM185 (TRPb) + BBa_K792010 (TRPZipper2) X YFP_TRPb_TRPZipper2 pCM185 (TRPb) + BBa_K792012 (PoliWb) X YFP_TRPb_PoliWb pEG202 (HIS) + BBa_K792009 (PoliHa) X CFP_HIS_PoliHa pEG202 (HIS) + BBa_K792011 (PoliHb) X CFP_HIS_PoliHb
Week 3: Synthetic Ecology Characterization
xxoo
Devices characterization
Secretion Rate of Trp as a function of culture growth
The first step was to actually check if the construct works: do the transformed yeast strains - with the TRP BB - actually secrete TRP into the medium?
To test this we used the following strains:
- YFP_TRPb_TRPZipper2
- YFP_TRPb_PolyWb
- YFP_TRPb
- YFP_TRPa_TRPZipper2
- YFP_TRPa_PolyWb
- YFP_TRPa
- YFP
Protocol
- We started 5ml cultures with 3 replica until they reached exponential phase, overnight, using a -T medium.
- Starting OD for the assay 0.1 (exponential phase).
- We measured OD every hour until they reached an OD: 0.8 (5 hs approximately).
- We measured the Trp signal for each culture medium using the spectrofluorometer.
We used a simple model to measure the export rate for all the strains. Since the cultures are in exponential phase, we take
After a few calculations, we find that
Next we show the average temporal evolution for each strains used,
Figure X. check
Tryptophan secretion at increasing histidine concentrations
We asked ourselves which was the dependance of tryptophan secretion on the amount of histidine in medium. We carried on this test in order to determine if wether the secretion of tryptophan depends of the concentretation of another amino acid in media, such as histidine, or not. ¿the necessary amount of histidine in medium for the start of our system?
Protocol
- Starters of YFP_TRPa_TRPZipper2, YFP_TRPb_TRPZipper2 and YFP_TRPa (control) strains were grown over night in -T media, at 30 °C in shaker.
- After 12 hs, cells were pelleted and washed with -HT media.
- Cultures with increasing concentrations of histidine (0X, 1X, 1/4X and 1/16X) were set at an initial OD: 0.1, for each strain with 2 replica.
- We left the cultures in shaker at 30ºC for 5 hours. After that time, we measured the final OD reached by cultures with the use of a spectrophotometer and the amount of tryptophan present in medium with a spectrofluorometer.
Results
Strain characterization
Experimental determination of strains death rate
We set out to determine how long can auxotrophic cells[link] survive in media that lacks both Trytophan and Histidine. These values are the death parameters for CFP and YFP strains used in our model[link]. These were taken as equal in the mathematical analysis for simplicity, we'll test whether this approximation is accurate.
Given that our system most likely will present a lag phase until a certain amount of both AmioAcids is accumulated in the media, will the cells be viable until this occurs? This is a neccesary check of our system's feasability.
Protocol
- We set cultures of the two auxotrophic strains without being transformed (YFP and CFP) in medium –HT at an initial OD of 0.01.
- Each day we plated the same amount of µl of the culture and counted the number of colonies obtain in each plate. We set 3 replica of each strain.
Table: Number of colonies counted per plate. We expect to see a decrease in the number of colonies - because of cell death. We found that this was not the case, in the experiment's time lapse. However we observed that the size of the colonies was smaller everyday. We can infer from this data that though they have not died, they may have enter into a ...Alan state.
FigureX. Growth dependence on the Trp and His concentrationAn important thing to characterize of the system is the dependence of the growth rate of the culture with the concentration of the crossfeeding aminoacids, tryptophane (Trp) and histidine (His). This would allow us to estimate one of the parameters used in our model (EC50, the amount of aminoacid at which the culture reaches half of the maximum growth).
Protocol1. We would use strains YFP and CFP (non-transformed, without devices) which are auxotroph for His and Trp. We started cultures of 5 ml of initial OD: 0.025 for: - Strain YFP at the following media [Trp] = 1x; 0.5x; 0.25x; 0.125x; 0.0625x, 0.03125x - Strain CFP at the following media [His] = 1x; 0.5x; 0.25x; 0.125x; 0.0625x, 0.03125x - Strain YFP at Synthetic Complete media - Strain CFP at Synthetic Complete media 2. Cultures would be left overnight (12 hs) at 30°C with agitation and we measured OD reached with the use of spectrophotometer. ResultsTo be done! Coculture of transformed strainsWe did the first experiment to test whether our system works and how two transformed strains grow together. We designed an assay to do so; following the growth of these strains:
Protocol
Results |
